Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective, Open Label Clinical Trial on the Use of Convalescent Plasma Compared to Best Supportive Care in Patients With Severe COVID-19

NCT04433910 is registered in ClinicalTrials.gov with Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen as lead sponsor.

NCT NCT04433910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04433910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective, Open Label Clinical Trial on the Use of Convalescent Plasma Compared to Best Supportive Care in Patients With Severe COVID-19
Lead sponsor
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen
Phase
Phase 2
Overall status
Completed
Start date
August 30, 2020
Completion date
March 25, 2022
Enrollment
106 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19